Ipsen to Buy Swiss Biotech Memo in Deal That Could Top $800 Million
(feeds.content.dowjones.io)
1.
2.
Harmonizing standards and resources for the medical genome
(feeds.nature.com)
3.
Ipsen to Buy Kartos Therapeutics for Up to $1.75 Billion
(feeds.content.dowjones.io)
4.
5.
AbbVie to Buy Apogee Therapeutics for $10.9 Billion in Cash
(feeds.content.dowjones.io)
6.
Eli Lilly, Ascidian Sign $1.9 Billion Kidney-Disease Treatment Deal
(feeds.content.dowjones.io)
7.
Developers: Get Your Medical Mobile App Verified By IEEE
(spectrum.ieee.org)
8.
9.
Bayer to Buy Eye-Drug Developer Perfuse Therapeutics for Up to $2.45 Billion
(feeds.content.dowjones.io)
10.
UCB to Buy Candid Therapeutics for Up to $2.2 Billion
(feeds.content.dowjones.io)
11.
Eli Lilly Strikes Deal for Cancer Biotech
(feeds.content.dowjones.io)
12.
Eli Lilly Nears Deal for Cancer Biotech
(feeds.content.dowjones.io)
13.
Neurocrine to Buy Soleno for Treatment for Rare Disease That Causes Relentless Hunger
(feeds.content.dowjones.io)
14.
Neurocrine to Buy Soleno for $2.9 Billion
(feeds.content.dowjones.io)
15.
HN: I simulated a real cancer case and predicted why some tumors didn't respond
(news.ycombinator.com)
16.
The most innovative biotech companies of 2026
(feeds.feedburner.com)
17.
A gene-editing method generates immunotherapeutic CAR T cells in the body
(feeds.nature.com)
18.
BioMarin to Buy Rare-Disease Biotech Amicus Therapeutics for $4.8 Billion
(feeds.content.dowjones.io)
19.
A skin-permeable polymer for non-invasive transdermal insulin delivery
(feeds.nature.com)
Today's top topics:
anthropic
apple
google
android authority
playstation
meta
sony
spacex
claude
openai